Latest News and Press Releases
Want to stay updated on the latest news?
-
Phoenix, AZ, Sept. 30, 2024 (GLOBE NEWSWIRE) -- In May of 2024, Louisiana enacted a law classifying mifepristone and misoprostol as Schedule IV controlled dangerous substances, akin to medications...
-
Dublin, May 10, 2021 (GLOBE NEWSWIRE) -- The "Gastrointestinal Drugs Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering....
-
TUCSON, Ariz., Dec. 18, 2019 (GLOBE NEWSWIRE) -- Abortion providers are encouraging women to choose the medical abortion option, but studies consistently show that the rate of complications is four...